Cell cycle arrest in endometrial carcinoma cells exposed to gonadotropin-releasing hormone analog

Gynecol Oncol. 1999 Jun;73(3):368-71. doi: 10.1006/gyno.1999.5398.

Abstract

Gonadotropin-releasing hormone (GnRH) has been shown to have an inhibitory effect on the growth of several hormone-dependent human tumors. We have treated a human endometrial cancer cell line which expresses GnRH receptor with GnRH analog, D-Trp6-LHRH, in order to study whether there are differences in cell cycle kinetic response. Flow cytometric analysis revealed that cultured carcinoma cells showed a cell cycle arrest at the G1-S transition after treatment with 10 microM D-Trp6-LHRH for 36 h. Western blot analysis showed that the level of p16 protein was obvious following 24 h of D-Trp6-LHRH treatment. These results suggest that the mechanism by which GnRH inhibits the growth of endometrial carcinoma cells may include effects on cell cycle arrest.

MeSH terms

  • Endometrial Neoplasms / genetics*
  • Female
  • Flow Cytometry
  • G1 Phase / drug effects*
  • Gonadotropin-Releasing Hormone / analogs & derivatives*
  • Gonadotropin-Releasing Hormone / pharmacology
  • Humans
  • Triptorelin Pamoate
  • Tumor Cells, Cultured

Substances

  • Triptorelin Pamoate
  • Gonadotropin-Releasing Hormone